A series of death cases raises questions about safety and oversight at detox centers

Trust is the first thing families hand over when they walk a loved one through the doors of a detox or residential treatment center, and the decision is almost never made calmly.

It tends to come within hours of an overdose or a phone call no family ever wants to take, with parents and spouses operating on the belief that medical oversight is already built into what is being provided. And the country is leaning on that assumption more heavily than ever.

The Substance Abuse and Mental Health Services Administration’s most recent national survey counted more than 17,800 substance use treatment facilities operating across the United States. And while 52.6 million Americans needed substance use treatment in 2024, only about 10.2 million received it.

Investor money has followed close behind that demand, and the ownership of these facilities looks very different from what it did a decade ago. A JAMA Psychiatry study from Oregon Health & Science University found private equity firms now hold stakes in roughly 7% of addiction treatment facilities nationwide.

In some states, behavioral health ownership by those same firms accounts for as much as a quarter of all facilities. And the rapid commercial growth is now running up against pointed questions about staffing levels and patient supervision during the most fragile hours of detox and withdrawal.

In California, where those questions have hardened into civil filings, attorneys at MSD Lawyers have tracked a recent wave of wrongful death cases against detox and residential facilities, with families alleging the 24/7 medical supervision they were promised did not exist in the hours their loved ones needed it most.

Why the Addiction Treatment Industry Is Growing So Quickly

Addiction treatment plays two roles in American healthcare. It is essential medicine that keeps people alive through detox and early recovery, and it is also a commercial market valued at more than $42 billion, with Future Market Insights projecting roughly $71 billion by 2035. Much of that commercial expansion traces back to a pair of federal laws.

The Mental Health Parity and Addiction Equity Act of 2008 and the Affordable Care Act of 2010 classified substance use disorder as an essential health benefit and forced insurers to cover behavioral care on the same terms as other medical care. Treatment beds that once leaned on out-of-pocket payments suddenly had insurance reimbursement flowing in, and private programs grew quickly around that new revenue.

New residential centers opened across the country, including high-end luxury programs that charge families directly for amenities and privacy beyond what insurance covers.

Corporate buyers and outside investors followed the same path, acquiring independent clinics and folding them into larger treatment networks. And marketing has kept pace, with call centers and search-driven referral systems often deciding which facilities a family even hears about.

The Oversight Problem Inside Detox and Residential Treatment

Most families assume rehab and detox centers run under the same strict rules as hospitals, but the reality is far less standardized. Oversight starts with the state, so a California facility may face different requirements than a program across state lines.

For example, licensing gives a facility legal permission to open its doors, while accreditation adds outside review from private groups such as the Joint Commission or CARF, the Commission on Accreditation of Rehabilitation Facilities. Accreditation is also often required for a facility to accept payment from private health insurance carriers.

Medical supervision rules also depend on how a state classifies the facility, so a medical detox center usually carries stricter requirements than a residential treatment program. And staffing shortages make those differences harder to see from the outside. For instance, overnight care may fall to behavioral health technicians (BHTs) with limited medical training rather than nurses. These BHTs are typically recovering addicts.

Even emergency readiness varies, especially at free-standing rehabs that are not built like hospitals. Verifying any of this on the spot is nearly impossible for a family, since no single public database compares staffing or incident records across facilities.

Patient Safety Concerns Now Driving Civil Litigation

The blind spots families face before admission are now being described in California court filings by relatives of patients who entered detox or residential treatment and never came home. A series of wrongful death complaints have been filed since late 2024, with each one raising separate allegations about what staff did or failed to do during the hours after admission.

The most disturbing involves 21-year-old Issac Charlton, who entered a Granada Hills detox program in May 2025 after 500 days of sobriety. His mother’s complaint alleges a staff member (a recovering addict himself) offered to supply Issac with controlled substances during his stay and instructed him to keep their conversations hidden from other staff. Issac died five days after admission of a combined fentanyl and diazepam overdose.

Jimmie Sizemore, a 47-year-old husband and father from Kentucky, admitted himself to a North Hollywood luxury center that billed his insurance $7,990 a day. His widow’s complaint alleges no staff member laid eyes on him for over nine hours, despite California law requiring visual checks every thirty minutes. By the time paramedics arrived, his body was already stiff with rigor mortis.

A similar pattern appears in the death of Alexander DeCarli, who was seeking sobriety for the first time and paid $8,500 a day at a Glendale facility advertising round-the-clock medical supervision. His mother’s complaint alleges he arrived with hypertension and severe withdrawal symptoms and was left overnight without any vital-sign monitoring. He was pronounced dead the next morning of a cardiac event after staff could not locate a defibrillator.

And Dean “Alice” Deily, a 21-year-old whose peanut allergy was documented at the top of nearly every page of her medical file, was served a snack containing peanuts at a San Diego treatment center and died of anaphylactic shock the same night.

Each complaint describes a different alleged failure, but the filings keep returning to the same pressure point. Families were paying for supervision and peace of mind during the hours when their loved ones were least able to protect themselves. The lawsuits now ask whether the care behind those promises matched the price, the advertising, and the medical risk.

How Financial Incentives Can Influence Care Models

Most private treatment programs run on a per-day reimbursement model, where insurance pays a set rate for every night a patient occupies a bed, and insurer reviewers decide when the plan will stop covering that level of care.

Empty beds become immediate revenue losses against high fixed costs, so marketing spend and paid referral systems become part of how many programs keep admissions moving. And that same pressure makes larger treatment networks attractive to investors, since buying multiple facilities can turn scattered beds into a bigger business platform.

Private equity activity in behavioral health now sits inside the national debate over healthcare consolidation, where growth can bring capital while also raising questions about control over care.

None of this means quality care and business growth cannot coexist. But operating a clinical program under financial targets raises legitimate questions about which patients get admitted and how quickly a facility moves to send a struggling patient to a higher level of care.

What Families Should Ask Before Choosing a Detox Facility

Picking a detox facility under the weight of a family crisis is one of the hardest choices most households will ever make, and the right questions up front are often the difference between a safe admission and a preventable tragedy. Before signing any admission paperwork, families should ask the following.

• Are licensed medical professionals physically onsite at all hours, and who specifically manage withdrawal symptoms or medication issues overnight?
• How does the facility handle a medical crisis, and how quickly do staff call 911 or transfer a patient to a hospital?
• Which state agency licenses the facility, and does it hold outside accreditation through the Joint Commission or CARF?
• What security measures are in place to ensure that illegal or unauthorized drugs don’t enter the facility?
• How often are patients checked during detox, and how are those checks recorded?
• Can the facility safely treat patients with psychiatric conditions or chronic medical issues like diabetes or heart disease?
• How are prescription medications secured and tracked, and how are food allergies flagged across the kitchen and clinical staff?
• How do families receive updates, and who contacts them during a medical concern?
• Are staffing policies, emergency procedures, and patient rights provided in writing before admission?

Where the Detox Industry Goes From Here

Detox is one of the hardest conversations a family ever has, but avoiding it does not make the need for treatment any smaller. Addiction care saves lives every day across the country, and most private facilities in this space are run by clinicians who take that responsibility seriously.

The push now coming from patient advocates and whistleblowers is not aimed at the existence of those programs but at the silence around safety incidents, staffing shortages, and ownership structures that families currently cannot see before admission.

For now, lawmakers and healthcare researchers remain split over whether the industry can police itself or whether stricter federal standards will be needed to close the weakest parts of detox care. But either way, demand for treatment will keep climbing, and the families filling those beds deserve to know what is waiting on the other side of the door.

This story was produced by MSD Lawyers and reviewed and distributed by Stacker.